Andrew Wang, MD, a UNC Lineberger member and associate professor in the UNC School of Medicine Department of Radiation Oncology, recently spoke about nanomedicine at a scientific advisory board meeting of the Organisation for the Prohibition of Chemical Weapons.
Wang traveled to The Hague in the Netherlands to address the Organisation for the Prohibition of Chemical Weapons‘ scientific advisory board on how new drugs, including nanomedicines, are being developed and used in clinical trials. The advisory board, comprised of 25 scientists from 25 different countries, provides counsel on scientific issues to the group’s policy makers.
An 192-state organization, OPCW responsible for implementing the Chemical Weapons Convention disarmament treaty, which became international law in 1997, with a goal of eliminating all chemical weapons.